Smooth muscle cell-specific matrix metalloproteinase 3 deletion reduces osteogenic transformation and medial artery calcification
Cardiovascular Research · 07.05.2024 · 120 (6) · 658-670
DOI: 10.1093/cvr/cvae035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 08.03.2024. Verfasst von Yangzhouyun Xie und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, Yale University School of Medicine, 330 Cedar St., BB 204, New Haven, C…. Hauptthemen laut MEDLINE: Gene Deletion, Matrix Metalloproteinase 3, Vascular Calcification. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCATS NIH HHS, US National Institutes of Health.
Abstract (Originalsprache)
Aims
Vascular calcification is highly prevalent in atherosclerosis, diabetes, and chronic kidney disease. It is associated with increased morbidity and mortality in patients with cardiovascular disease. Matrix metalloproteinase 3 (MMP-3), also known as stromelysin-1, is part of the large matrix metalloproteinase family. It can degrade extracellular matrix components of the arterial wall including elastin, which plays a central role in medial calcification. In this study, we sought to determine the role of MMP-3 in medial calcification. Methods and results We found that MMP-3 was increased in rodent models of medial calcification as well as in vascular smooth muscle cells (SMCs) cultured in a phosphate calcification medium. It was also highly expressed in calcified tibial arteries in patients with peripheral arterial disease (PAD). Knockdown and inhibition of MMP-3 suppressed phosphate-induced SMC osteogenic transformation and calcification, whereas the addition of a recombinant MMP-3 protein facilitated SMC calcification. In an ex vivo organ culture model and a rodent model of medial calcification induced by vitamin D3, we found that MMP-3 deficiency significantly suppressed medial calcification in the aorta. We further found that medial calcification and osteogenic transformation were significantly reduced in SMC-specific MMP-3-deficient mice, suggesting that MMP-3 in SMCs is an important factor in this process.
Conclusion
These findings suggest that MMP-3 expression in vascular SMCs is an important regulator of medial calcification and that targeting MMP-3 could provide a therapeutic strategy to reduce it and address its consequences in patients with PAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, Yale University School of Medicine, 330 Cedar St., BB 204, New Haven, CT 06510, USA.
- Division of Vascular and Endovascular Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 0221, USA.
ORCID-Profile: Yujun Cai, Raul J Guzman
Förderung
- NHLBI NIH HHS
- NCATS NIH HHS
- US National Institutes of Health
Zitieren
APA
Xie, Y., Lin, T., Jin, Y., Berezowitz, A. G., Wang, X. L., Lu, J., Cai, Y., & Guzman, R. J. (2024). Smooth muscle cell-specific matrix metalloproteinase 3 deletion reduces osteogenic transformation and medial artery calcification. Cardiovascular Research, 120(6), 658-670. https://doi.org/10.1093/cvr/cvae035
Vancouver
Xie Y, Lin T, Jin Y, Berezowitz AG, Wang XL, Lu J, et al. Smooth muscle cell-specific matrix metalloproteinase 3 deletion reduces osteogenic transformation and medial artery calcification. Cardiovascular Research. 2024;120(6):658-670. doi:10.1093/cvr/cvae035
BibTeX
@article{Xie2024,
author = {Xie, Yangzhouyun and Lin, Tonghui and Jin, Ying and Berezowitz, Alexa G and Wang, Xue-Lin and Lu, Jinny and Cai, Yujun and Guzman, Raul J},
title = {Smooth muscle cell-specific matrix metalloproteinase 3 deletion reduces osteogenic transformation and medial artery calcification},
journal = {Cardiovascular Research},
year = {2024},
volume = {120},
number = {6},
pages = {658--670},
doi = {10.1093/cvr/cvae035}
}
EUVIMED